Approvals/CIMA-AEMPS/ANIDULAFUNGINA SWANPOND INVESTMENTS 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

ANIDULAFUNGINA SWANPOND INVESTMENTS 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Swan Pond Investments Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 8f36bd57f81c081e
Drug Cima Aemps Name: ANIDULAFUNGINA SWANPOND INVESTMENTS 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 85815
Holder Company Name: Swan Pond Investments Limited
Marketing Company Name: Swan Pond Investments Limited
Authorization Date: 2021-02-26
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 100 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Swan Pond Investments Limited

ANIDULAFUNGINA

100 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 26, 2021

Approval ID

8f36bd57f81c081e

Type

Standard